MD410G2 - Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system - Google Patents

Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system

Info

Publication number
MD410G2
MD410G2 MD95-0344A MD950344A MD410G2 MD 410 G2 MD410 G2 MD 410G2 MD 950344 A MD950344 A MD 950344A MD 410 G2 MD410 G2 MD 410G2
Authority
MD
Moldova
Prior art keywords
remedy
tussue
rehabilitating
regulation system
mass
Prior art date
Application number
MD95-0344A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Tamara Vorobiova
Original Assignee
Tamara Vorobiova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamara Vorobiova filed Critical Tamara Vorobiova
Priority to MD95-0344A priority Critical patent/MD410G2/en
Publication of MD410G2 publication Critical patent/MD410G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Remedy consists of an active agent - merry dichloride or potassium arsenite, or sodium arsenite in a quantity of 0,01-1,5 mass % and diluent up to 100 mass %. The applicated remedy preferebly contains as diluent the white grapes wine containing sugar 3-4 mass % or milk serum with sugar content of 3-4 mass.%.
MD95-0344A 1995-08-14 1995-08-14 Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system MD410G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD95-0344A MD410G2 (en) 1995-08-14 1995-08-14 Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD95-0344A MD410G2 (en) 1995-08-14 1995-08-14 Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system

Publications (1)

Publication Number Publication Date
MD410G2 true MD410G2 (en) 1996-10-31

Family

ID=62142648

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0344A MD410G2 (en) 1995-08-14 1995-08-14 Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system

Country Status (1)

Country Link
MD (1) MD410G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD27Z (en) * 2008-10-24 2010-01-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method for treating disorders of cellular immunity caused by the ionizing radiation
WO2023123690A1 (en) * 2021-12-30 2023-07-06 中国民航大学 Concealed grouting and void risk evaluation method for cement concrete pavement slab edge

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Лекарственные средства", 1992, "Медицина", Moscova, vol. 2, p. 169-170. *
"Лекарственные средства", 1992, "Медицина", Moscova, vol. 2, p. 423-468. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD27Z (en) * 2008-10-24 2010-01-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method for treating disorders of cellular immunity caused by the ionizing radiation
WO2023123690A1 (en) * 2021-12-30 2023-07-06 中国民航大学 Concealed grouting and void risk evaluation method for cement concrete pavement slab edge

Similar Documents

Publication Publication Date Title
PT973413E (en) NUTRITIONAL FORMULATIONS THAT CONTAIN LACTO-N-NEOTETRAOSE
CA2241266A1 (en) Enzyme composition for tissue dissociation
CA2325379A1 (en) Composition for improving glucose and insulin metabolism in companion animals
TR200000122T2 (en) Bright white film coatings and related film coating compositions.
AU2260097A (en) Hematopoietic cell culture nutrient supplement
ES8801930A1 (en) N,N-dialkylguanidino dipeptides.
CA2116221A1 (en) Animal cell culture
CA2188950A1 (en) Functional expression of mammalian adenylyl cyclase in yeast
DE69907240D1 (en) FIXED PHYTASE COMPOSITIONS
IL108157A0 (en) An enzyme with endoglucanase activity
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
CA2311756A1 (en) Reduction of hair growth
BR9405351A (en) Combined action of endoglucanases and cellobiohydrolases
AU6974294A (en) Release and mobilisation of haematopoietic cells
HK1052198A1 (en) Metabollically engineered cells overexpressing pyruvate carboxylase or pyruvate phosphoenolpyruvate carbokylase, and methods to produce and use such cells
CA2240296A1 (en) Endothelial cell proliferation inhibitor and method of use
CA2230159A1 (en) Use of aminoadamantane compounds as immunoregulators
AU2633997A (en) Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
MD410G2 (en) Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system
MX9407877A (en) Solid culture substrate including barley.
WO1996036220A3 (en) Insecticidal composition containing diatomaceous earth and silica
ES2097706A1 (en) Cockroach repellent composition.
ZA966803B (en) Cell culture products.
WO1991010721A3 (en) Process for high cell density fermentation of escherichia coli in an agitated boiler fermenter
IL117097A0 (en) Substituted heterocycloalkenes their preparation and use